Nombre del producto |
Mezcla variable de K-estrofantina |
Sinónimos |
k-estrofantósido; NSC 7530; ESTRONFANTÓSIDO-K; Estrofantidina cimarosa beta-glucosa alfa-glucosa; Estrofantidina cimarosa beta-glucosa alfa-glucosa [alemán]; k-Strofantozyd; k-Strofantozyd [polaco]; k-Estrofantidina-gamma; k-Estrofantósido; k-Estrofantosida [alemán]; k-Estrofantósido; (3beta,5beta)-3-((O-beta-D-glucopiranosil-(1,6)-O-beta-D-glucopiranosil-(1,4)-2,6-didesoxi-3-O-metil-beta-D-ribo-hexopiranosil)oxi)-5,14-dihidroxi-19-oxocard-20(22)-enólido; 5-beta-Card-20(22)-enólido, 3-beta-((O-beta-D-glucopiranosil-(1-6)-O-beta-D-glucopiranosilo-(1-4)-2,6-didesoxi-3-O-metil-beta-D-ribo-hexopiranosil)oxi)-5,14-dihidroxi-19-oxo-; Card-20(22)-enólido, 3-((O-beta-D-glucopiranosil-(1-6)-O-beta-D-glucopiranosilo-(1-4)-2,6-dideoxi-3-O-metil-beta-D-ribo-hexopiranosil)oxi)-5,14-dihidroxi-19-oxo-, (3beta,5beta)- (9CI); 3-{[hexopiranosil-(1->6)hexopiranosil-(1->4)-2,6-didesoxi-3-O-metilhexopiranosil]oxi}-5,14-dihidroxi-19-oxocard-20(22)-enólido; (3beta,5beta,17xi)-3-{[beta-D-glucopiranosil-(1->6)-beta-D-glucopiranosil-(1->4)-2,6-didesoxi-3-O-metil-beta-D-ribo-hexopiranosil]oxi}-5,14-dihidroxi-19-oxocard-20(22)-enólido |
Nombre en inglés |
K-strophanthin variable mixture;k-Strophanthoside; NSC 7530; STROPHANTHOSIDE-K; Strophanthidin + cymarose + beta-glucose + alpha-glucose; Strophanthidin + cymarose + beta-glucose + alpha-glucose [German]; k-Strofantozyd; k-Strofantozyd [Polish]; k-Strophanthidin-gamma; k-Strophantosid; k-Strophantosid [German]; k-Strophantoside; (3beta,5beta)-3-((O-beta-D-glucopyranosyl-(1.6)-O-beta-D-glucopyranosyl-(1.4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxocard-20(22)-enolide; 5-beta-Card-20(22)-enolide, 3-beta-((O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranosyl-(1-4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-; Card-20(22)-enolide, 3-((O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranosyl-(1-4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)- (9CI); 3-{[hexopyranosyl-(1->6)hexopyranosyl-(1->4)-2,6-dideoxy-3-O-methylhexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide; (3beta,5beta,17xi)-3-{[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide |
Fórmula molecular |
C42H64O19 |
Peso Molecular |
872.9462 |
InChI |
InChI=1/C42H64O19/c1-19-36(61-38-35(51)33(49)31(47)27(60-38)17-56-37-34(50)32(48)30(46)26(15-43)59-37)25(54-3)13-29(57-19)58-21-4-9-40(18-44)23-5-8-39(2)22(20-12-28(45)55-16-20)7-11-42(39,53)24(23)6-10-41(40,52)14-21/h12,18-19,21-27,29-38,43,46-53H,4-11,13-17H2,1-3H3/t19-,21+,22?,23+,24-,25+,26-,27-,29+,30-,31-,32+,33+,34-,35-,36-,37-,38+,39-,40+,41+,42+/m1/s1 |
Número de registro CAS |
33279-57-1 |
EINECS |
251-439-1 |
Estructura Molecular |
|
Densidad |
1.49g/cm3 |
Punto de ebullición |
1027.2°C at 760 mmHg |
Índice de refracción |
1.631 |
Punto de inflamación |
304°C |
Presión de vapor |
0mmHg at 25°C |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|